Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. - Wikidata - wikimedia - TriplyDB

Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen.

Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen.

http://www.wikidata.org/entity/Q34619914

about

Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy Natural Polyphenols for Prevention and Treatment of Cancer Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature Anticancer Efficacy of Polyphenols and Their Combinations Curcumin as a Modulator of P-Glycoprotein in Cancer: Challenges and Perspectives Recent progress on nutraceutical research in prostate cancer.The role of GATA2 in lethal prostate cancer aggressiveness.The role of soy in vegetarian diets Multiple therapeutic and preventive effects of 3,3'-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia.Curcumin and cancer: barriers to obtaining a health claim.Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial.The multifaceted role of curcumin in cancer prevention and treatment.Estrogens and prostate cancer: etiology, mediators, prevention, and management.Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.The role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomes Epigenetic activities of flavonoids in the prevention and treatment of cancer Therapeutic roles of curcumin: lessons learned from clinical trials.Cancer cell signaling pathways targeted by spice-derived nutraceuticals.Curcumin suppresses NTHi-induced CXCL5 expression via inhibition of positive IKKβ pathway and up-regulation of negative MKP-1 pathway.Future directions in the prevention of prostate cancer.Curcumin, a component of turmeric: from farm to pharmacy.Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers Advances in prostate cancer chemoprevention: a translational perspective.Nutrition and prostate cancer: an overview.Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms.Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment.Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.Curcumin and Its Role in Chronic Diseases.Curcumin, Piperine, and Capsaicin: A Comparative Study of Spice-Mediated Inhibition of Human Cytochrome P450 Isozyme Activities.Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells.Testosterone augments polyphenol-induced DNA damage response in prostate cancer cell line, LNCaP.Chemoprevention of prostate cancer: soy isoflavones and curcumin.Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells.Modulation of AKR1C2 by Curcumin Decreases Testosterone Production in Prostate Cancer.Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations

P2860

Q24597964-779B4C71-AEE1-41C8-9D79-BE125E3982EC Q26739022-9F7843C3-076D-4DAC-83CF-5613DF66B2F2 Q28071946-64A86ED6-F13A-4893-B842-2A159C13A524 Q28076137-2D34605A-FCDC-4A29-AFAE-E6648E5DA2EB Q28078369-1EA8B41D-4F50-45C9-97DD-A6DF7DE0D5EC Q33818800-B8D54166-CA58-4FDE-BF35-900D10FC8F4F Q33848134-50F27124-49FA-4588-95CA-7D016745C585 Q34247970-A5F4E6DD-3686-4DBF-9853-9897ACF2119E Q34340728-D2720EAF-DBA2-4B8F-8864-93391B81FF3E Q34478532-810E322D-9F0A-49F6-BFA4-2BED3C474AF6 Q34660475-16A3B276-B651-4761-BD06-9126A611F81A Q34667865-63573291-332B-4F11-9F36-A0B705F21DDF Q35196710-67E06CD3-4EBE-45C3-BC32-373207FA6A22 Q35358778-2DEFBA0A-D663-49C6-9DBE-71FDEE4DACA3 Q35609249-8C624D10-3D5C-45C5-8095-2E82332AA457 Q35835175-23D16AA1-6C93-4DEB-89D2-AFE01F36978D Q36502400-DD9F1F01-B0A1-4C4B-A966-BA91A555B05A Q36819371-6E95BCCE-A69B-40A6-A0C9-138BA8234F94 Q37188938-F18DDA98-3A50-4FD7-A21B-A8972F42DD83 Q37279094-C349DD6A-BE4E-4FE0-9660-6B51DB62F700 Q38075863-B59EEB15-205B-436A-9A1D-38B0E77C51D9 Q38083084-49741A1F-4A3B-432B-A076-DB5200B6859C Q38107513-0F351F69-F4E8-4843-833B-4CD029EA6C70 Q38264784-E375BE72-6C86-4539-9593-CD431669435C Q38668187-94E05D0F-1B34-4E8D-8D7E-E0AD2009EB81 Q38790667-3790963B-EFDB-41B7-A68D-9ED4C7C7F0D1 Q38818485-0E11D8D3-E9C5-49D3-921C-DE4B1E03C23A Q38957154-D475616A-065A-4BDB-8311-70F534B4C139 Q38965184-3B6A4DD2-6803-4728-8574-B9D3168A1446 Q39207677-C3FF7B84-C8A2-4B27-8528-E73D34888961 Q39410020-3C077C68-27E1-4246-A808-F2F8D4FD6807 Q39470443-DB0EFB21-2633-4991-B309-488949ABDA35 Q39623453-D739C525-24C0-4808-8569-33B4E1911703 Q41466203-9F0733DD-27AE-4ABB-AF75-B756E58A6F1A Q42151185-F52BC095-C740-432E-805C-157B24172D86 Q49711327-A6CBBE09-2206-429C-84EF-967F4CC5A519 Q57109257-DC4FB82D-D071-49AC-B94B-483B17902125

P2860

Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen.

http://www.wikidata.org/entity/Q34619914

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Combined inhibitory effects of ...... of prostate-specific antigen.

@ast

Combined inhibitory effects of ...... of prostate-specific antigen.

@en

Combined inhibitory effects of ...... of prostate-specific antigen.

@nl

type

label

Combined inhibitory effects of ...... of prostate-specific antigen.

@ast

Combined inhibitory effects of ...... of prostate-specific antigen.

@en

Combined inhibitory effects of ...... of prostate-specific antigen.

@nl

prefLabel

Combined inhibitory effects of ...... of prostate-specific antigen.

@ast

Combined inhibitory effects of ...... of prostate-specific antigen.

@en

Combined inhibitory effects of ...... of prostate-specific antigen.

@nl

P1433

Q34619914-67EADCCE-0B74-4019-8C17-B6AD3D80ECD7

P1476

Q34619914-702D0F3A-F642-4B33-ABB2-6144DC044AFE

P2093

Q34619914-02F57EF8-39D2-49F7-9F26-9570DD82B953

Q34619914-15FDF7DD-6A0D-42EC-83B6-7DB8D02E52BA

Q34619914-27BB8E42-6D1E-42B4-9B1B-8C57309BF84F

Q34619914-2D592A6B-61EE-4892-BD2D-F6D8E4E6369F

Q34619914-2F8BC052-C184-4644-81CA-17FAE289EB6E

Q34619914-300362EF-15B4-40D8-9D7E-C64EA0020165

Q34619914-51BBA6C4-578B-49D9-BF77-2B2857F63CCA

Q34619914-59632034-9C23-44E6-925A-BA6237A9BE39

Q34619914-63BBCE9A-BBF1-41CD-A3B4-784FC4118FF9

P2860

Q34619914-278AB1C4-2C49-4651-B499-5EBA6C4B7939

Q34619914-73D7BF34-941F-4132-BFB2-7D7C1E8028ED

P304

Q34619914-1BF9DF25-7B64-4239-8E77-5EB6F223D917

P31

Q34619914-093A837B-C607-4FCF-9F10-1D45074D5732

P356

Q34619914-EFC9208F-9B62-48BF-8D9D-E1B7A6391F11

P433

Q34619914-214DBD12-B320-48EA-B35E-57180C7AFEEA

P478

Q34619914-2CCA5F97-87F2-4A91-8D65-A5DF96B5EB72

P577

Q34619914-8EF5C4CF-6968-421A-8270-747A5B8235EB

P698

Q34619914-2351B325-18D9-4ABF-9D3D-FCE396C976E7

P921

Q34619914-35110c0c-915e-4de4-8b06-7b1cba13feef

P356

P1433

P1476

Combined inhibitory effects of ...... of prostate-specific antigen.

@en

P2093

Hiroko Masuda

http://www.w3.org/2001/XMLSchema#string

Hisamitsu Ide

http://www.w3.org/2001/XMLSchema#string

Kentaro Sakamaki

http://www.w3.org/2001/XMLSchema#string

Koujiro Nishio

http://www.w3.org/2001/XMLSchema#string

Satoru Muto

http://www.w3.org/2001/XMLSchema#string

Shigeo Horie

http://www.w3.org/2001/XMLSchema#string

Shino Tokiwa

http://www.w3.org/2001/XMLSchema#string

Shuji Isotani

http://www.w3.org/2001/XMLSchema#string

Takanori Hama

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular effects of the isoflavonoid genistein in prostate cancer.

p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.

P304

1127-1133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.21147

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20503397

http://www.w3.org/2001/XMLSchema#string

P921